Cited by 524Trace Elements in HealthHeavy Metal Exposure and ToxicityNeurological diseases and metabolism

The role of zinc, copper, manganese and iron in neurodegenerative diseases

Mezzaroba, Leda, Alfieri, Daniela Frizon, Colado Simão, Andrea Name, Vissoci Reiche, Edna Maria·2019·NeuroToxicology

Abstract

Metals are involved in different pathophysiological mechanisms associated with neurodegenerative diseases (NDDs), including Alzheimer's disease (AD), Parkinson's disease (PD) and multiple sclerosis (MS). The aim of this study was to review the effects of the essential metals zinc (Zn), copper (Cu), manganese (Mn) and iron (Fe) on the central nervous system (CNS), as well as the mechanisms involved in their neurotoxicity. Low levels of Zn as well as high levels of Cu, Mn, and Fe participate in the activation of signaling pathways of the inflammatory, oxidative and nitrosative stress (IO&NS) response, including nuclear factor kappa B and activator protein-1. The imbalance of these metals impairs the structural, regulatory, and catalytic functions of different enzymes, proteins, receptors, and transporters. Neurodegeneration occurs via association of metals with proteins and subsequent induction of aggregate formation creating a vicious cycle by disrupting mitochondrial function, which depletes adenosine triphosphate and induces IO&NS, cell death by apoptotic and/or necrotic mechanisms. In AD, at low levels, Zn suppresses β-amyloid-induced neurotoxicity by selectively precipitating aggregation intermediates; however, at high levels, the binding of Zn to β-amyloid may enhance formation of fibrillar β-amyloid aggregation, leading to neurodegeneration. High levels of Cu, Mn and Fe participate in the formation α-synuclein aggregates in intracellular inclusions, called Lewy Body, that result in synaptic dysfunction and interruption of axonal transport. In PD, there is focal accumulation of Fe in the substantia nigra, while in AD a diffuse accumulation of Fe occurs in various regions, such as cortex and hippocampus, with Fe marginally increased in the senile plaques. Zn deficiency induces an imbalance between T helper (Th)1 and Th2 cell functions and a failure of Th17 down-regulation, contributing to the pathogenesis of MS. In MS, elevated levels of Fe occur in certain brain regions, such as thalamus and striatum, which may be due to inflammatory processes disrupting the blood-brain barrier and attracting Fe-rich macrophages. Delineating the specific mechanisms by which metals alter redox homeostasis is essential to understand the pathophysiology of AD, PD, and MS and may provide possible new targets for their prevention and treatment of the patients affected by these NDDs.

Integrity signals

Registry

Crossref · 10.1016/j.neuro.2019.07.007

Cites

109 of 109 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In Alzheimer disease, zinc at physiological levels suppresses β-amyloid-induced neurotoxicity by selectively precipitating aggregation intermediates; at high levels, zinc binding to β-amyloid may enhance fibrillar β-amyloid aggregation, leading to neurodegeneration.

    “in patients suffering from Alzheimer disease, zinc at physiological levels suppresses β-amyloid-induced neurotoxicity by selectively precipitating aggregation intermediates; however, at high levels, the binding of zinc to β-amyloid may rather enhance fibrillar β-amyloid aggregation, leading to neurodegeneration [194].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Mezzaroba, L., Alfieri, D. F., Colado Simão, A. N., & Vissoci Reiche, E. M.
Affiliations
Universidade Estadual de Londrina (BR)
Venue
NeuroToxicology
Publisher
Elsevier BV
Published
2019-09
Volume
74
Pages
230-241
ISSN
0161-813X (ISSN-L)
OpenAlex
W2966510508
Cited by
524
References
109
Citations by year
2026: 48 · 2025: 101 · 2024: 107 · 2023: 79 · 2022: 84 · 2021: 60 · 2020: 44 · 2019: 1
FWCI
6.44
Type
journal article
Language
en
Open access
closed
Locations
  • NeuroToxicology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
  • Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Heavy Metal Exposure and Toxicity
  • Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
Keywords
zinc, copper, manganese, iron, neurodegenerative diseases, Alzheimer's disease, Parkinson's disease, multiple sclerosis, metal neurotoxicity, amyloid-beta aggregation, alpha-synuclein, Lewy bodies, iron accumulation, Th1/Th2 imbalance, Th17 cells, redox homeostasis, mitochondrial dysfunction, apoptosis, blood-brain barrier, neuroinflammation
MeSH terms
Animals, Copper, Humans, Iron, Manganese, Zinc, Neurodegenerative Diseases, Manganese Poisoning

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review